H1B Salary Data

Home › Employers › Specialty PharmaSource LLC

Specialty PharmaSource LLC: H-1B salaries and sponsorship

Specialty PharmaSource LLC filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $59,000.

Applications (LCAs)4
Certified4
Employer addressDenville, NJ
H-1B dependent employerNo
Median offered salary$59,000
Middle half of salaries$58,000–$61,250
10th–90th percentile$58,000–$63,500

Does Specialty PharmaSource LLC sponsor H-1B visas?

Specialty PharmaSource LLC filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 15, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Regulatory Affairs Specialist2$61,500
QC Analyst1$60,000
Market Research Analyst1$58,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$59,000
FY20241$58,000
FY20261$65,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Regulatory Affairs Specialist$65,000
Level I
Denville, NJJun 15, 2026Jun 22, 2026Certified
Market Research Analyst$58,000
Level I
Denville, NJJun 17, 2024Oct 1, 2024Certified
QC Analyst$60,000
Level II
Denville, NJAug 22, 2023Oct 1, 2023Certified
Regulatory Affairs Specialist$58,000
Level I
Denville, NJJun 5, 2023Oct 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).